Megan Hayes

Synthesis and Cardiac Imaging of (18)F-Ligands Selective for β1-Adrenoreceptors.

P. Yalamanchili, S. Robinson, T. Harris, 2011, ACS medicinal chemistry letters.

Abstract 1914: BMS753951: A Novel Low Molecular Weight Magnetic Resonance Contrast Agent Selective For Arterial Wall Imaging

S. Robinson, P. Yalamanchili, T. Harris, 2007 .

Amino Acid derived enamides: synthesis and aminopeptidase activity.

P. Yalamanchili, R. Cesati, D. Casebier, 2007, Organic letters.

Synthesis and biological evaluation of pyridazinone analogues as potential cardiac positron emission tomography tracers.

S. Robinson, P. Yalamanchili, A. Purohit, 2008, Journal of medicinal chemistry.

Mechanism of uptake and retention of F-18 BMS-747 158-02 in cardiomyocytes: a novel PET myocardial imaging agent

S. Robinson, P. Yalamanchili, A. Purohit, 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Quinazoline derivatives as MC-I inhibitors: evaluation of myocardial uptake using Positron Emission Tomography in rat and non-human primate.

S. Robinson, A. Purohit, M. Azure, 2007, Bioorganic & medicinal chemistry letters.

Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates

S. Robinson, P. Yalamanchili, A. Purohit, 2008, European Journal of Nuclear Medicine and Molecular Imaging.

Synthesis and biological evaluation of the mitochondrial complex 1 inhibitor 2-[4-(4-fluorobutyl)benzylsulfanyl]-3-methylchromene-4-one as a potential cardiac positron emission tomography tracer.

S. Robinson, P. Yalamanchili, M. Azure, 2007, Journal of Medicinal Chemistry.

[18F](R)-5-chloro-1-(1-cyclopropyl-2-methoxyethyl)-3-(4-(2-fluoroethoxy)-2,5-dimethyl phenylamino)pyrazin-2(1H)-one: introduction of N3-phenylpyrazinones as potential CRF-R1 PET imaging agents.

Vijay T. Ahuja, J. Macor, T. Molski, 2012, Bioorganic & medicinal chemistry letters.